Solid Pharmaceutical Dosage Form Comprising An Hiv Protease Inhibitor Solid Dispersion

Patent No. EP2258346 (titled "Solid Pharmaceutical Dosage Form Comprising An Hiv Protease Inhibitor Solid Dispersion") was filed by Abbott on Aug 23, 2004. The application was issued on Sep 27, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
F HOFFMANN LA ROCHEJun 26, 2018VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2258346

ABBOTT
Application Number
EP10181268A
Filing Date
Aug 23, 2004
Status
Revoked
Jul 10, 2020
Publication Date
Sep 27, 2017